CAS RN: 1228631-19-3
benzyl 3,5-dioxopiperidine-1-carboxylate
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1228631-19-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1228631-19-3 / benzyl 3,5-dioxopiperidine-1-carboxylate
Standard CAS: 1228631-19-3
Multi CAS: No
Basic Information
copy
CAS
1228631-19-3 copy
Multi CAS
No copy
Molecular Formula
C13H13NO4 copy
Molecular Weight
247.250000 copy
Exact Mass
247.084458 copy
SMILES
C1C(=O)CN(CC1=O)C(=O)OCC2=CC=CC=C2 copy
InChI
InChI=1S/C13H13NO4/c15-11-6-12(16)8-14(7-11)13(17)18-9-10-4-2-1-3-5-10/h1-5H,6-9H2 copy
InChIKey
LWXKJIHFJCWJGM-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
18 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.31 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
Molar refractivity
62.83 copy
TPSA
63.68 copy
LogP / Solubility
WLOGP
1.17 copy
MLOGP
1.03 copy
XLogP3
1.2 copy
Consensus LogP
1.13 copy
Log S (ESOL)
-2.22 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.43 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.48 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.4 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy